Skip to main content
. 2017;18(4):1151–1156. doi: 10.22034/APJCP.2017.18.4.1151

Table 3.

The Effect of Trastuzumab Therapy with Recurrence

Event Censoring Hazard Ratio Median Follow Up 95% CI P value (Log-rank test)
Local recurrence 6 months 15 11 2.6 55 44-66 0.049
12 months 4 28 61 49-73
Distant metastasis 6 months 9 11 2.4 43 29-57 0.074
12 months 1 8 46 37-55